The relationship between levothyroxine dosage and free thyroxine levels in hypothyroid patients: a large retrospective study
Authors' conclusion
The findings emphasize the importance of higher free thyroxine levels for maintaining adequate free triiodothyronine in levothyroxine-treated patients, underscoring the need to monitor free thyroxine, free triiodothyronine, and their ratio during therapy to optimize treatment outcomes. In addition, clinicians should recognize that higher levothyroxine doses may elevate free thyroxine levels beyond the reference range.
Study context
- Population
- Hypothyroid patients; excluded: TRAb-positive or treated with antithyroid drugs (thiamazole, PTU, potassium iodide); July 2021–March 20243,020 FT4 measurements
- Participants
- 1,409 patients
- Exposure
- LT4-treated vs untreated patients
- Outcome
- FT4 levels (Elecsys FT4 III immunoassay)
Main finding
As reported in the abstract
FT4
P < 0.0001
Observational data: associations, not effects.
Further findings
| Outcome | LT4-treated | Untreated | P value |
|---|---|---|---|
| FT3/FT4 ratioLower with LT4-treated | 0.24 (IQR 0.20–0.29) | 0.28 (IQR 0.25–0.32) | P < 0.0001 |
Dose relationship
- FT4 increased with LT4 dosage, whereas the FT3/FT4 ratio decreased
TSH
- TSH did not differ significantly between groups; higher LT4 doses associated with mild suppression
Original publication
The relationship between levothyroxine dosage and free thyroxine levels in hypothyroid patients: a large retrospective study. Eur Thyroid J. Published 4 July 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →